Search results
AstraZeneca confirms strong vaccine protection after US rift
AOL· 6 days agoAstraZeneca insists that its COVID-19 vaccine is strongly effective even after counting additional...
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric...
FOX 8 Cleveland· 7 days agoNovartis today announced that the U.S. Food and Drug Administration (FDA) approved Lutathera®...
Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno...
Digital Journal· 6 days agoIRVINE, CA / ACCESSWIRE / April 24, 2024 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease ...
Nearly half of mothers report birth trauma and barriers to mental health aid, especially for diverse...
Medical Xpress· 7 days agoFor Williams, she needed multiple surgeries after delivery due to a pulmonary embolism and blood...
Pfizer Gets FDA OK For Beqvez Gene Therapy for Hemophilia B
Market Watch· 4 days agoPfizer has won Food and Drug Administration approval of Beqvez, a one-time gene therapy for certain patients with the inherited bleeding disorder hemophilia B. The New York drugmaker on Friday ...
Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno...
The Eagle-Tribune· 6 days agoIRVINE, CA / ACCESSWIRE / April 24, 2024 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease ...
Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly...
FOX 5 San Diego· 4 days agoSobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of efanesoctocog alfa, for ...